Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Avg
|
New words:
absorption, ACR, Actemra, andreatta, anthracycline, anti, Apomab, aseptic, AVADO, Bao, Barron, BC, BioInvent, blocker, broke, carcinoid, cardiovascular, Celgene, Cephalon, certified, certolizumab, cGMP, choice, chondrosarcoma, Cimzia, CNTO, coli, College, Compendia, conceded, confer, configure, conjugate, constantly, core, Council, covenant, decide, defense, demolition, destination, Diego, disagreed, displayed, Dixon, doubtful, ductal, equivalent, error, ESPP, extraordinary, Galicia, golimumab, ground, Hal, HCP, headquarter, heard, highest, histology, HopeLink, host, incidence, indemnify, interval, jurisdiction, KGaA, KPMG, landscape, leveraged, Likewise, lived, Martinez, mg, myelodysplastic, nearest, neck, neutral, notified, Notwithstanding, nucleic, ocular, Ophthalmology, outlay, overcome, overnight, pancreactic, partner, passed, pegol, permanent, perspective, placebo, platform, Pontevedra, preexisting, prepayment, pronouncement, reform, Regeneron, resign, Retina, revealed, Revlimid, revolving, Rheumatology, RHI, RIBBON, sample, SERENE, situ, solid, sputum, subcutaneously, sublease, sue, SUNRISE, technique, TNF, Torisel, Town, Treanda, Ubaldo, UCB, unrecognized, vinorelbine, voluntarily, weakened, week, weekly, withdrew, ZEST
Removed:
absorb, accrual, amend, applying, Armour, begun, beneficiary, BNP, CEO, CFO, chemical, consolidate, declined, Depot, dimerization, discounting, dismissed, Eastern, encapsulated, entirety, esteemed, foot, Garnick, GMP, growing, Hampshire, injectable, issuing, john, leasing, multicenter, Myrtle, natural, Omnitarg, Portsmouth, Potter, priority, promissory, reached, reducing, reliable, reliably, replace, restructured, retroactive, rhDNase, rhuFab, scale, Serono, space, suspension, Topical, twelve, unamortized, variety, VIE, whiting, write, XOMA
Filing tables
Filing exhibits
- 10-K Annual report
- 10.9 Genentech, Inc. Tax Reduction Investment Plan, As Amended and Restated
- 10.17 Form of Genentech, Inc. 2004 Equity Incentive Plan Nonqualified Stock Option Grant Agreement (Employee Version)
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended
- 31.2 Certification of Chief Financial Officer Pursuant to Rules 13A-14(A) and 15D-14(A) Promulgated Under the Securities Exchange Act of 1934, As Amended
- 32.1 Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.s.c. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
Related press release
Genentech similar filings
Filing view
External links